These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8106057)
1. [The combined use of alpha-adrenoblockaders and calcium antagonists in the etiopathogenetic therapy of cardiovascular diseases]. Sytnik SI; Denisov SL Eksp Klin Farmakol; 1993; 56(4):26-30. PubMed ID: 8106057 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular drug therapy in the elderly. Aronow WS; Frishman WH; Cheng-Lai A Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484 [TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists in the treatment of cardiovascular diseases (review of the literature)]. Chekman IS; Nizhenkovskaia IV Vrach Delo; 1982 Sep; (9):47-52. PubMed ID: 6294997 [No Abstract] [Full Text] [Related]
4. [Current aspects of the mechanism of action of calcium antagonists in patients with diabetes mellitus]. Kostiuk OP; Zubkova ST Fiziol Zh (1978); 1992; 38(3):106-11. PubMed ID: 1499754 [TBL] [Abstract][Full Text] [Related]
5. Calcium-channel antagonists in cardiovascular disease. Holdright DR Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
7. [Calcium antagonists--determination of current status and therapeutic significance]. Regenthal R; Voigt H; Preiss R Z Gesamte Inn Med; 1992 Dec; 47(12):573-82. PubMed ID: 1283652 [TBL] [Abstract][Full Text] [Related]
9. [Effects of calcium channel blockers in atherosclerosis and cardiovascular event and oxidative vascular damage]. Fujino T; Sumitomo K; Hasebe N; Kikuchi K Clin Calcium; 2004 Jan; 14(1):119-27. PubMed ID: 15576967 [TBL] [Abstract][Full Text] [Related]
10. Preoperative pharmacological management of phaeochromocytoma. van der Horst-Schrivers AN; Kerstens MN; Wolffenbuttel BH Neth J Med; 2006 Sep; 64(8):290-5. PubMed ID: 16990692 [TBL] [Abstract][Full Text] [Related]
11. [Primary acrosyndrome. Treatment combining an alpha-blocked and a calcium blocker]. Stamm D; David L; Ninet J; François R Arch Fr Pediatr; 1987; 44(7):505-7. PubMed ID: 2892476 [TBL] [Abstract][Full Text] [Related]
12. Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations. Parati G J Cardiovasc Pharmacol; 2009 May; 53(5):352-8. PubMed ID: 19365281 [TBL] [Abstract][Full Text] [Related]
13. Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade. Bell DS Curr Med Res Opin; 2005 Aug; 21(8):1191-200. PubMed ID: 16083528 [TBL] [Abstract][Full Text] [Related]
14. Combination of alpha-blockers with other antihypertensive drugs. Reddy KS; Prabhakaran D J Assoc Physicians India; 1998; Suppl 1():22-5. PubMed ID: 11229105 [No Abstract] [Full Text] [Related]
18. [Differentiated use of calcium antagonists. Current therapy of cardiovascular diseases]. Internist (Berl); 1999 Oct; 40(10 Suppl Moderne):1-4. PubMed ID: 10549001 [No Abstract] [Full Text] [Related]
19. [Calcium antagonists. Pharmacology and clinical pharmacology]. Grobecker H Med Monatsschr Pharm; 1994 May; 17(5):130-9. PubMed ID: 8022361 [No Abstract] [Full Text] [Related]
20. The current status of calcium antagonists in cardiovascular therapy. Chia BL; Ee BK; Tan AT; Choo M Singapore Med J; 1982 Apr; 23(2):121-7. PubMed ID: 7135002 [No Abstract] [Full Text] [Related] [Next] [New Search]